Search

Your search keyword '"Pizzolo, G"' showing total 804 results

Search Constraints

Start Over You searched for: Author "Pizzolo, G" Remove constraint Author: "Pizzolo, G"
804 results on '"Pizzolo, G"'

Search Results

1. Differences among young adults, adults and elderly chronic myeloid leukemia patients

2. P1709: FERTILITY PRESERVATION FOR YOUNG ADULT ACUTE LYMPHOBLASTIC LEUKEMIAS IN ITALY: A CAMPUS ALL SURVEY.

3. P357: MULTICENTER RETROSPECTIVE ANALYSIS OF CLINICAL OUTCOME OF ADULT PATIENS WITH MIXED-PHENOTYPE ACUTE LEUKEMIA (MPAL) DIAGNOSED AND TREATED IN THE LAST TEN YEARS. A CAMPUS-ALL STUDY.

4. P1708: PREGNANCIES IN YOUNG ADULTS WITH A HISTORY OF ACUTE LYMPHOBLASTIC LEUKEMIA IN ITALY. A CAMPUS ALL SURVEY.

5. Differences among young adults, adults and elderly chronic myeloid leukemia patients

6. Rapid reconstitution of functionally active 6-sulfoLacNAc+ dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant

7. EFFICACY AND DISCONTINUATION RATE OF IBRUTINIB IN TREATMENT NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH TP53 ABNORMALITIES. A REAL‐LIFE CAMPUS CLL STUDY

24. S1620 NELARABINE AS SALVAGE THERAPY AND BRIDGE TO ALLOGENEIC STEM CELLS TRANSPLANTATION IN 118 ADULT PATIENTS WITH RELAPSED/REFRACTORY T-ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA. A CAMPUS-ALL, PHASE 4, STUDY.

30. Pneumologie

32. Clinico-biologic features of 5202 acute lymphoblastic leukemia patients enrolled in the Italian AIEOP and GIMEMA Protocols and stratified in age-cohorts

33. Combination of Rituximab, Bendamustine and Cytarabine (R-BAC) for Patients With Mantle Cell Non-Hodgkin's ineligible for intensive regimens or autologous transplantation. Lymphoma Ineligible for Intensive Regimens or Autologous Transplantation

35. Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib

36. MAKING THE RIGHT CHOICE: THE ROLE OF FITNESS STATUS IN THE MANAGEMENT OF FIRST-LINE TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS (CLL FITNESS STUDY)

37. Pro-apoptotic activity of α-bisabolol in preclinical models of primary human acute leukemia cells

39. TIME OF PERIPHERAL BLOOD PROGENITOR CELL COLLECTIONS MAY INFLUENCE THE RISK OF SECONDARY MYELODYSPLASTIC SYNDROME/ACUTE LEUKEMIA FOLLOWING INTENSIVE THERAPY AND AUTOGRAFT: A GITIL SURVEY ON 1,347 LYMPHOMA PATIENTS RECEIVING THE HIGH-DOSE SEQUENTIAL PROGRAM

40. IMPACT OF KIT MUTATIONS IN ACUTE MYELOID LEUKAEMIA WITH INV(16)

41. Prevalence and prognostic impact of KIT mutations in acute myeloid leukaemia with INV(16)

42. Update of a GITIL cohort study: Frontline high dose sequential chemotherapy with rituximab and autologous stem cell transplantation induces a high rate of long-term remissions in patients with mantle cell lymphoma

43. Molecular screening of PDGFRA and PDGFRB genes in KIT and FLT3 negative core binding factor leukemias

44. The risk of secondary myelodysplastic syndrome/acute leukemia following intensive therapy and autograft correlates with the type of cells grafted: A survey on 1,347 lymphoma patients receiving the high-dose sequential (HDS) program

45. Rituximab markedly improves the efficacy of high-dose programmes with autograft for B-cell lymphoma: a multicentre GITIL survey on 957 patients

46. Heparin-Binding Epidermal Growth Factor–Like Growth Factor/Diphtheria Toxin Receptor Expression by Acute Myeloid Leukemia Cells

47. Benefit of rituximab addition to high-dose programs with autograft for B-cell lymphoma: A multicenter GITIL survey on 957 patients

50. Presenting features and outcome of Splenic Marginal Zone Lymphoma with or without villous lymphocytes. A retrospective analysis in a Series of 145 Patients

Catalog

Books, media, physical & digital resources